BioCentury is the Companys flagship publication, serving a worldwide audience in the biopharma, investment and public policy communities. This audience values BioCenturys independence, fact-based reporting, strategic perspective and in-depth approach to industry-shaping events.
BioCentury Week in Review provides a weekly compendium of biopharma deals, clinical and regulatory events, and financial transactions.